Global Hypertrophic & Keloid Scar Treatment Market Worth Around $10.5 Billion By 2026: Acumen Research and Consulting

Author: Acumen Research and Consulting

The global hypertrophic & keloid scar treatment market size is projected to around USD 10.5 billion by 2026, the market is projected to grow with 10.0% CAGR during the forecast time frame. This can be credited to the rising consciousness about aesthetic appearance. Therefore, increasing need for numerous processes to improve the aesthetic appeal is possible to increase the market growth in the years to come.

Scar treatment delivers complete skin rejuvenation, therefore improving aesthetic appeal. The need for aesthetic products mostly exists among women, due to which they are the major consumers of these products. Also, increase in the numeral of road accidents and burn cases has also influenced the development of the hypertrophic and keloid scar treatment market.

Download Report Sample Pages For Better Understanding@ 

More than 40,000 hospitalizations resulted from burn injuries, the statics is as per American Burn Association, in 2016. This indicates an increase in the numeral of burn injuries worldwide. These injuries cause visible hypertrophic scars a common complication associated with them. Though, road accidents, leading to surgeries, can result in the growth of surgical marks.

These factors, paired with subsequent rise in the numeral of cosmetic processes, has accelerated the need for topical products. Though, treatment with laser therapies delivers faster and effective results. Furthermore, they are slightly invasive and eliminate pain, due to which they are the most preferred treatment option.


Increase in consciousness regarding aesthetic appeal has led to the market development. As per Plastic Surgery Statistics Report, around 182,321 reconstructive processes for scar revision were performed in 2017. Henceforth, the need for reconstructive processes also plays a significant role in boost up the market development.

Increase in burn injury cases has also led to augmented need for hypertrophic and keloid scar treatments. Plastic surgeries or resurfacing laser therapies are usually performed to eliminate these marks. Hypertrophic burn marks can affect a victim’s appearance and are related with other conditions, for instance,contractures and pruritis.

The introduction of technically advanced products, for instance, laser therapies, will also support industry growth. These products assistance reduce scars caused owing to trauma injuries, burns, and surgery. For example, Non-ablative laser therapy destroys scar tissues through vascularization with the aid of a pulsed dye laser. Though, exorbitant prices of laser products are expected to hamper the market development.

The global hypertrophic & keloid scar treatment market is segmented into product, end-user, and region. On the basis of product the global hypertrophic & keloid scar treatment market is segmented into topical products, laser products, injectable, and others. The topical products sub segment is further bifurcated into silicone sheets, creams, gels, and others. The laser product sub- segment is further bifurcated into pulse-dyed, co2 and others. On the basis of end-user, the global hypertrophic & keloid scar treatment market is segmented into hospitals, clinics, and retail pharmacies/E-commerce. On the basis of scare type the market is bifurcated into Hypertrophic and Keloid.On the basis of region the global Hypertrophic & Keloid Scar Treatment market is segmented into Latin America, Europe, Asia Pacific, North America, and Middle East & Africa.

In 2018, North America captures the largest market share and is expected to observer steady growth during the forthcoming years. High prevalence of skin-related disorders, burn injuries, and trauma are among the main factors accountable for the market growth. Furthermore, accessibility and acceptance of progressive treatment options, for instance, laser treatments, are projected to support the development.

Scar treatment for burn injuries is enclosed under government compensation policies in U.S., which is also expected to have an optimistic impact on the regional industry. Europe also produced a substantial revenue in 2018 due to increase in the numeral of National Health Services (NHS) plastic surgery units and centers in U.K. This region has favorable compensation policies that make it a lucrative regional industry.

Asia Pacific is expected to observer the fastest CAGR over the forecast time frame due to obtainability of technically progressive products and occurrence of a large numeral of producers in nations, for instance, China. Accessibility of laser instruments at cheaper prices in developing countries has increased their acceptance, thus pushing market growth. Due to high incidence of burn injuries, India has also backed considerably to the region’s development.

The key players catering to the global hypertrophic & keloid scar treatment market are Sonoma Pharmaceuticals, Inc., Lumenis Ltd.,Suneva Medical, Inc., Smith & Nephew PLC,Mölnlycke Health Care AB, Cynosure, Inc., and Enaltus, LLC.


The report is readily available and can be dispatched immediately after payment confirmation.

Buy this premium research report - 

Would like to place an order or any question, please feel free to contact at | +1 407 915 4157